BAMCO Inc’s Clovis Oncology, Inc. CLVS Stock Holding History

BAMCO Inc’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-29,147	Closed	-$2.4M	–	330
2017 Q3	$2.4M	Buy	29,147 +14,132	+94%	+$1.12M	0.01%	264
2017 Q2	$1.41M	Buy	+15,015	New	+$919K	0.01%	291

Other funds holding CLVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

BAMCO Inc's CLVS Position: Q4 2017 in Review

BAMCO Inc sold out of Clovis Oncology, Inc. (CLVS) in Q4 2017, closing a stake of 29,147 shares — an estimated $2.4M sold.

BAMCO Inc first reported a position in CLVS in Q2 2017 and held it in 2 quarters. The position peaked at $2.4M in Q3 2017. 247 funds tracked by Wall St. Rank hold CLVS as of Q4 2017.

BAMCO Inc reported no remaining Clovis Oncology, Inc. position as of Q4 2017 after selling out during the quarter.
BAMCO Inc sold 29,147 Clovis Oncology, Inc. shares in Q4 2017, an estimated $2.4M.
BAMCO Inc first reported a position in Clovis Oncology, Inc. in Q2 2017 and held it in 2 quarters.
BAMCO Inc's Clovis Oncology, Inc. position peaked at $2.4M in Q3 2017.
247 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2017.

Based on BAMCO Inc's 13F filing for Q4 2017, filed 14 Feb 2018.